•
Jan 31, 2020

Cooper Q1 2020 Earnings Report

CooperCompanies' first quarter of 2020 resulted in increased revenue and decreased GAAP and non-GAAP diluted earnings per share compared to the previous year.

Key Takeaways

CooperCompanies reported a 3% increase in revenue to $646.2 million. GAAP diluted earnings per share decreased by 12% to $1.82, and Non-GAAP diluted earnings per share decreased by 7% to $2.69.

Revenue increased 3% year-over-year to $646.2 million.

CooperVision (CVI) revenue increased 3% to $485.2 million.

CooperSurgical (CSI) revenue increased 2% to $161.0 million.

Non-GAAP diluted earnings per share was $2.69, a decrease of 7% from last year's first quarter.

Total Revenue
$646M
Previous year: $628M
+2.9%
EPS
$0.67
Previous year: $0.72
-6.9%
Gross margin
66%
Previous year: 67%
-1.5%
Operating margin
17%
Previous year: 18%
-5.6%
Gross Profit
$427M
Previous year: $419M
+1.9%
Cash and Equivalents
$76.8M
Previous year: $147M
-47.6%
Free Cash Flow
$60.7M
Previous year: $22.6M
+168.6%
Total Assets
$6.55B
Previous year: $6.3B
+4.0%

Cooper

Cooper

Cooper Revenue by Segment

Cooper Revenue by Geographic Location

Forward Guidance

The Company updated its fiscal year 2020 guidance. Fiscal 2020 total revenue is expected to be between $2,767 - $2,817 million (~5% to 7% constant currency). CVI revenue is expected to be $2,070 - $2,100 million (~5.5% to 7% constant currency) and CSI revenue $697 - $717 million (~3% to 6% constant currency). Fiscal 2020 non-GAAP diluted EPS of $12.80 - $13.20.

Revenue & Expenses

Visualization of income flow from segment revenue to net income